- Home
- CDRE vs PRME Comparison
CDRE vs PRME Comparison
Compare CDRE & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDRE
- PRME
- Stock Information
- Founded
- CDRE 2012
- PRME 2019
- Country
- CDRE United States
- PRME United States
- Employees
- CDRE N/A
- PRME N/A
- Industry
- CDRE Industrial Specialties
- PRME Medicinal Chemicals and Botanical Products
- Sector
- CDRE Health Care
- PRME Health Care
- Exchange
- CDRE Nasdaq
- PRME Nasdaq
- Market Cap
- CDRE 1.2B
- PRME 191.7M
- IPO Year
- CDRE 2021
- PRME 2022
- Fundamental
- Price
- CDRE $32.23
- PRME $3.14
- Analyst Decision
- CDRE Buy
- PRME Buy
- Analyst Count
- CDRE 2
- PRME 6
- Target Price
- CDRE $37.50
- PRME $9.38
- AVG Volume (30 Days)
- CDRE 297.7K
- PRME 3.7M
- Earning Date
- CDRE 08-08-2025
- PRME 08-04-2025
- Dividend Yield
- CDRE 1.18%
- PRME N/A
- EPS Growth
- CDRE N/A
- PRME N/A
- EPS
- CDRE 0.95
- PRME N/A
- Revenue
- CDRE $559,807,000.00
- PRME $3,846,000.00
- Revenue This Year
- CDRE $13.31
- PRME $104.12
- Revenue Next Year
- CDRE $7.96
- PRME $196.78
- P/E Ratio
- CDRE $34.04
- PRME N/A
- Revenue Growth
- CDRE 10.06
- PRME 550.76
- 52 Week Low
- CDRE $27.07
- PRME $1.11
- 52 Week High
- CDRE $40.28
- PRME $6.75
- Technical
- Relative Strength Index (RSI)
- CDRE 43.48
- PRME 79.25
- Support Level
- CDRE $31.58
- PRME $2.28
- Resistance Level
- CDRE $32.36
- PRME $2.78
- Average True Range (ATR)
- CDRE 0.88
- PRME 0.34
- MACD
- CDRE -0.23
- PRME 0.12
- Stochastic Oscillator
- CDRE 19.02
- PRME 81.62
About CDRE Cadre Holdings Inc.
Cadre Holdings Inc is engaged in the design and manufacture of a diversified product portfolio of critical safety and survivability equipment to protect first responders, federal agencies, outdoor recreation, and personal protection markets. The Company's equipment provides critical protection to allow its users to safely and securely perform their duties and protect those around them in hazardous or life-threatening situations. Its operations are comprised of two reportable segments: Products and Distribution.
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.